With effect from February 1, the cost of long-established prescription medicines in Ireland has been reduced by 40%, the Irish Pharmaceutical Healthcare Association (IPHA) announced, which could save the nation's patients as much as 500 euros ($695) a year.
The IPHA, which represents the international research-based pharmaceutical industry, has set up a special web site on which patients can check to see if their medicines are listed, and the price reduction. This carries a detailed list of all the medicines and their new, lower prices and includes some of the most commonly prescribed medicines in the country.
Commenting on the initiative, Brian Murphy, IPHA's director of commercial affairs, said: 'We would urge patients to check the web site as those who have to pay for their medicines could save 3 euros-4 euros on every 10 euros they spend. That's a potential saving of up to 500 euros per year.'
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze